Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pablo Barreiro

Showing results (61-70 of 220) with videos related to

Pageof 22
Sort By:
Antiviral Therapy|August 9, 2014
Long-term survival and liver-related events after pegylated interferon/ribavirin therapy in HIV-infected patients with chronic hepatitis CPablo Labarga, José V Fernández-Montero, Carmen de Mendoza, et al.
Annals of Medicine|April 11, 2014
Management and treatment of chronic hepatitis B in HIV-positive patientsVincent Soriano, Carmen de Mendoza, José V Fernández-Montero, et al.
Expert Opinion on Drug Metabolism & Toxicology|June 19, 2014
Pharmacogenetics of antiretroviral therapyPablo Barreiro, José Vicente Fernández-Montero, Carmen de Mendoza, et al.
Antiviral Research|February 19, 2014
Towards hepatitis C eradication from the HIV-infected populationPablo Barreiro, Jose Vicente Fernandez-Montero, Carmen de Mendoza, et al.
HIV Clinical Trials|April 3, 2003
Avascular necrosis in HIV-infected patients receiving antiretroviral treatment: study of seven casesMa Eulalia Valencia, Pablo Barreiro, Vicente Soriano, et al.
Current Opinion in Investigational Drugs (London, England : 2000)|August 27, 2005
Nucleoside/nucleotide backbones for the treatment of HIV infectionPablo Barreiro, Inmaculada Jiménez-Nácher, Benito García, et al.
Expert Review of Clinical Pharmacology|March 30, 2018
Treatment and prevention of HIV infection with long-acting antiretroviralsLaura Benítez-Gutiérrez, Vicente Soriano, Silvia Requena, et al.
AIDS Reviews|July 11, 2008
Risk for immune-mediated liver reactions by nevirapine revisitedJosé Medrano, Pablo Barreiro, Paula Tuma, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|June 26, 2012
Different impact of IL28B polymorphisms on response to peginterferon-α plus ribavirin in HIV-positive patients infected with HCV subtypes 1a or 1bEugenia Vispo, Norma I Rallon, Pablo Labarga, et al.
AIDS (London, England)|March 20, 2010
Noncirrhotic portal hypertension in HIV-infected patients: unique clinical and pathological findingsEugenia Vispo, Alberto Moreno, Ivana Maida, et al.
Pageof 22

Showing results (61-70 of 220) with videos related to

Sort By:
Pageof 22
Antiviral Therapy|August 9, 2014
Long-term survival and liver-related events after pegylated interferon/ribavirin therapy in HIV-infected patients with chronic hepatitis CPablo Labarga, José V Fernández-Montero, Carmen de Mendoza, et al.
Annals of Medicine|April 11, 2014
Management and treatment of chronic hepatitis B in HIV-positive patientsVincent Soriano, Carmen de Mendoza, José V Fernández-Montero, et al.
Expert Opinion on Drug Metabolism & Toxicology|June 19, 2014
Pharmacogenetics of antiretroviral therapyPablo Barreiro, José Vicente Fernández-Montero, Carmen de Mendoza, et al.
Antiviral Research|February 19, 2014
Towards hepatitis C eradication from the HIV-infected populationPablo Barreiro, Jose Vicente Fernandez-Montero, Carmen de Mendoza, et al.
HIV Clinical Trials|April 3, 2003
Avascular necrosis in HIV-infected patients receiving antiretroviral treatment: study of seven casesMa Eulalia Valencia, Pablo Barreiro, Vicente Soriano, et al.
Current Opinion in Investigational Drugs (London, England : 2000)|August 27, 2005
Nucleoside/nucleotide backbones for the treatment of HIV infectionPablo Barreiro, Inmaculada Jiménez-Nácher, Benito García, et al.
Expert Review of Clinical Pharmacology|March 30, 2018
Treatment and prevention of HIV infection with long-acting antiretroviralsLaura Benítez-Gutiérrez, Vicente Soriano, Silvia Requena, et al.
AIDS Reviews|July 11, 2008
Risk for immune-mediated liver reactions by nevirapine revisitedJosé Medrano, Pablo Barreiro, Paula Tuma, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|June 26, 2012
Different impact of IL28B polymorphisms on response to peginterferon-α plus ribavirin in HIV-positive patients infected with HCV subtypes 1a or 1bEugenia Vispo, Norma I Rallon, Pablo Labarga, et al.
AIDS (London, England)|March 20, 2010
Noncirrhotic portal hypertension in HIV-infected patients: unique clinical and pathological findingsEugenia Vispo, Alberto Moreno, Ivana Maida, et al.
Pageof 22